Canary Capital and 21Shares have been quite swift, officially submitting the spot ETF application for Injective to the SEC.
It seems that institutions are becoming increasingly diverse in their appetite, no longer satisfied with just Bitcoin and Ethereum, and are starting to dig into high-performance public chains. From a chip perspective, this type of application directly elevates the narrative level of INJ to the ranks of institutional assets, effectively obtaining a 'certificate of eligibility' for the mainstream market. However, given the SEC's usual slow pace, this is likely to be a protracted battle, so don't expect the documents to be submitted and take off immediately. This wave represents a typical game of bullish expectations, with capital flows indicating that large funds are starting to be 'picky' in the public chain sector. That said, is this momentum aiming to ETF-ify the top market cap assets? #ETF #Crypto #SEC #Injective $INJ
